TMED3 and hereditary clear cell renal cell carcinoma: TMED3 was identified as a prognostic biomarker of renal cell carcinoma, since higher TMED3 expression levels were found in high-stage and -grade cohorts when compared to low-stage and -grade cohorts (Ha et al., 2019).